REG - Iofina PLC - Appointment of Chrystal Capital Partners LLP

IofinaAnnouncement

20/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220620:nRST3854Pa&default-theme=true

RNS Number : 3854P  Iofina PLC  20 June 2022

20 June 2022

 

Iofina plc

("Iofina", the "Company" or the "Group")

(LSE AIM: IOF)

 

Appointment of Chrystal Capital Partners LLP as Strategic Financial Advisor

 

Iofina plc, manufacturers of specialty chemical products and specialists in
the exploration and production of iodine, today announces the appointment of
Chrystal Capital Partners LLP ("Chrystal Capital") as a financial advisory
partner. Chrystal Capital will be providing strategic advice on the Company's
approach to the equity markets and business growth, including helping to
engage with new investment funds, Single Family Offices (SFOs), and Ultra High
Net Worth Individuals (UHNWIs).

Iofina is one of the lowest cost raw iodine and iodine derivative companies in
the world. With spot iodine prices recently reaching $70/kg and demand high
for iodine derivatives, market conditions are in Iofina's favour. Debt has
been significantly reduced, and with five iodine productions plants in
operation and vertical integration into iodine derivatives through Iofina
Chemical, along with plans for additional iodine plants, the Company is in its
strongest ever position.

Against this backdrop, in addition to organic growth within our core
businesses, the Company will further explore business partnerships and
combinations in the market and explore wider opportunities to drive
shareholder value with the support of Chrystal Capital.

Commenting, President and CEO Dr. Tom Becker, stated: "Over the past few years
we have worked hard to position Iofina as one of the lowest cost iodine
producers in the world in a market that continues to show solid growth. The
appointment of Chrystal Capital Partners solidifies our intent to consider and
evaluate opportunities to grow the business beyond our organic growth plans.
We look forward to working closely with Chrystal Capital to assess how we can
further unlock and drive shareholder value going forward".

Kingsley Wilson, Partner at Chrystal Capital Partners, stated: "Having been
involved with Iofina as a private company, and subsequently bringing it to the
London market in 2008, I'm personally delighted to be working with the Iofina
management team again to assist in the next stage of growth to build value.
The iodine and iodine derivatives market globally is in robust health and
there are multiple opportunities for Iofina, with a strong market reputation
and solid financial strength, to take advantage of to scale the existing
business. We look forward to working with the Company to assess and execute
its strategic plan".

 

 

 

 

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +1 859 356 8000

 

Christopher Raggett/Tim Harper (Corporate Finance)

Tim Redfern/Barney Hayward (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4760

 

Media Contact:

Charles Goodwin/Laurie Gelhorn

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221

About Iofina:

www.iofina.com (http://www.iofina.com)

 

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen specialty chemicals
derived from raw iodine, as well as non-iodine based products for over 38
years.

 

About Chrystal Capital Partners LLP:

Chrystal Capital Partners LLP ("Chrystal"), is an entrepreneurial corporate
finance and investment house with an established global network of Single
Family Offices, Ultra High Net Worth Individuals and private equity
co-investment partners. Chrystal's core sector focus are Digital Economy,
Health & Wellness and Sustainable & Impact Investments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFLRRLIALIF